Form 8-K - Current report:
SEC Accession No. 0001140361-22-001029
Filing Date
2022-01-10
Accepted
2022-01-10 08:53:21
Documents
41
Period of Report
2022-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10032676_8k.htm   iXBRL 8-K 29769
2 EXHIBIT 99.1 brhc10032676_ex99-1.htm EX-99.1 52767
6 brhc10032676_ex99-1slide1.jpg GRAPHIC 106938
7 brhc10032676_ex99-1slide2.jpg GRAPHIC 374030
8 brhc10032676_ex99-1slide3.jpg GRAPHIC 189938
9 brhc10032676_ex99-1slide4.jpg GRAPHIC 209726
10 brhc10032676_ex99-1slide5.jpg GRAPHIC 172142
11 brhc10032676_ex99-1slide6.jpg GRAPHIC 141363
12 brhc10032676_ex99-1slide7.jpg GRAPHIC 176754
13 brhc10032676_ex99-1slide8.jpg GRAPHIC 190474
14 brhc10032676_ex99-1slide9.jpg GRAPHIC 180259
15 brhc10032676_ex99-1slide10.jpg GRAPHIC 153625
16 brhc10032676_ex99-1slide11.jpg GRAPHIC 155419
17 brhc10032676_ex99-1slide12.jpg GRAPHIC 175985
18 brhc10032676_ex99-1slide13.jpg GRAPHIC 201975
19 brhc10032676_ex99-1slide14.jpg GRAPHIC 174298
20 brhc10032676_ex99-1slide15.jpg GRAPHIC 188329
21 brhc10032676_ex99-1slide16.jpg GRAPHIC 163291
22 brhc10032676_ex99-1slide17.jpg GRAPHIC 143612
23 brhc10032676_ex99-1slide18.jpg GRAPHIC 164743
24 brhc10032676_ex99-1slide19.jpg GRAPHIC 165432
25 brhc10032676_ex99-1slide20.jpg GRAPHIC 228251
26 brhc10032676_ex99-1slide21.jpg GRAPHIC 164094
27 brhc10032676_ex99-1slide22.jpg GRAPHIC 141459
28 brhc10032676_ex99-1slide23.jpg GRAPHIC 74202
29 brhc10032676_ex99-1slide24.jpg GRAPHIC 190774
30 brhc10032676_ex99-1slide25.jpg GRAPHIC 149595
31 brhc10032676_ex99-1slide26.jpg GRAPHIC 93521
32 brhc10032676_ex99-1slide27.jpg GRAPHIC 181978
33 brhc10032676_ex99-1slide28.jpg GRAPHIC 163533
  Complete submission text file 0001140361-22-001029.txt   6866603

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plrx-20220110.xsd EX-101.SCH 3923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20220110_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20220110_pre.xml EX-101.PRE 16042
35 EXTRACTED XBRL INSTANCE DOCUMENT brhc10032676_8k_htm.xml XML 4081
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 22519890
SIC: 2834 Pharmaceutical Preparations